Showing results (1781-1790 of 1,798) with videos related to

Sort By:
Pageof 180
Actas Dermo-Sifiliograficas|October 27, 2023
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.
Actas Dermo-Sifiliograficas|January 19, 2024
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD StudyM Sánchez-Díaz, Á Flórez, M Ara-Martín, et al.
Communications Biology|October 18, 2023
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infectionsPatrick Y A Reinke, Edmarcia Elisa de Souza, Sebastian Günther, et al.
Acta Dermato-Venereologica|October 25, 2021
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)Alejandra Tomás-Velázquez, Onofre Sanmartin-Jiménez, Joan R Garcés, et al.
Clinical Cardiology|November 30, 2023
American Registry of Ambulatory or acutely decompensated heart failure (AMERICCAASS Registry): First 1000 patientsJuan Esteban Gómez-Mesa, Juliana María Gutiérrez-Posso, Manuela Escalante-Forero, et al.
Bioscience|September 8, 2025
The immeasurable value of plankton to humanityMaria Grigoratou, Susanne Menden-Deuer, Abigail McQuatters-Gollop, et al.
Molecular Genetics and Metabolism|January 10, 2026
Diagnosis, treatment, and follow-up of Fabry disease in pediatricsJuan Guillermo Cárdenas-Aguilera, Kelly Rocío Chacón-Acevedo, Ana María Zarante-Bahamón, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 11, 2024
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)Carlos Abril-Pérez, Miguel Mansilla-Polo, Begoña Escutia-Muñoz, et al.
Pageof 180